Mingxia Zhou

1.9k total citations
49 papers, 1.4k citations indexed

About

Mingxia Zhou is a scholar working on Molecular Biology, Cancer Research and Plant Science. According to data from OpenAlex, Mingxia Zhou has authored 49 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 15 papers in Cancer Research and 7 papers in Plant Science. Recurrent topics in Mingxia Zhou's work include Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (8 papers) and MicroRNA in disease regulation (6 papers). Mingxia Zhou is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (8 papers) and MicroRNA in disease regulation (6 papers). Mingxia Zhou collaborates with scholars based in China, United States and Germany. Mingxia Zhou's co-authors include Yingwei Chen, Fucheng He, Yingying Shi, Cong Zhang, Peng Du, Jing He, Wensong Ge, Weimin Xu, Junkai Yan and Jin Wu and has published in prestigious journals such as Angewandte Chemie International Edition, Immunity and Oncogene.

In The Last Decade

Mingxia Zhou

42 papers receiving 1.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mingxia Zhou 911 400 231 148 127 49 1.4k
Hae Ryoun Park 964 1.1× 316 0.8× 167 0.7× 165 1.1× 236 1.9× 104 2.1k
Feng Zhu 948 1.0× 423 1.1× 242 1.0× 178 1.2× 223 1.8× 62 1.7k
Jing Xu 726 0.8× 370 0.9× 203 0.9× 177 1.2× 259 2.0× 113 1.6k
Yan Ma 813 0.9× 196 0.5× 137 0.6× 112 0.8× 160 1.3× 79 1.4k
Chi-Meng Tzeng 800 0.9× 228 0.6× 138 0.6× 92 0.6× 161 1.3× 63 1.4k
Ge Wang 1.2k 1.3× 507 1.3× 113 0.5× 137 0.9× 83 0.7× 44 1.6k
Tingting Fang 825 0.9× 312 0.8× 176 0.8× 127 0.9× 191 1.5× 82 1.6k
Mohammadreza Sharifi 1.2k 1.3× 795 2.0× 158 0.7× 93 0.6× 171 1.3× 98 1.8k
Xuan Xu 773 0.8× 290 0.7× 94 0.4× 143 1.0× 160 1.3× 63 1.4k

Countries citing papers authored by Mingxia Zhou

Since Specialization
Citations

This map shows the geographic impact of Mingxia Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingxia Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingxia Zhou more than expected).

Fields of papers citing papers by Mingxia Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingxia Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingxia Zhou. The network helps show where Mingxia Zhou may publish in the future.

Co-authorship network of co-authors of Mingxia Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Mingxia Zhou. A scholar is included among the top collaborators of Mingxia Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingxia Zhou. Mingxia Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chang, Dan Du, Jie Yin, et al.. (2025). CircNF1 modulates the progression and immune evasion of esophageal squamous cell carcinoma through dual regulation of PD-L1. Cellular & Molecular Biology Letters. 30(1). 37–37. 5 indexed citations
2.
Wu, Kai, Vita A. Kondratenko, Mingxia Zhou, et al.. (2025). The Role of Reducibility of PtGaO x ‐Based Catalysts for Efficient and Durable Propane Dehydrogenation. Angewandte Chemie International Edition. 64(31). e202506704–e202506704.
3.
Huang, Wei, Mingxia Zhou, Qiang Ma, et al.. (2025). Emerging role of Itaconate in inflammatory bowel disease: From multitarget Immunometabolic mechanisms to therapeutic translation. International Immunopharmacology. 166. 115632–115632.
5.
Zhou, Mingxia, et al.. (2024). Designing a Candidate Multi-Epitope Vaccine against Transmissible Gastroenteritis Virus Based on Immunoinformatic and Molecular Dynamics. International Journal of Molecular Sciences. 25(16). 8828–8828. 6 indexed citations
6.
Zhou, Mingxia, Jing He, Yingxia Li, et al.. (2023). N6-methyladenosine modification of REG1α facilitates colorectal cancer progression via β-catenin/MYC/LDHA axis mediated glycolytic reprogramming. Cell Death and Disease. 14(8). 557–557. 24 indexed citations
7.
Zhou, Mingxia, et al.. (2023). High-fructose corn syrup aggravates colitis via microbiota dysbiosis-mediated Th17/Treg imbalance. Clinical Science. 137(20). 1619–1635. 14 indexed citations
8.
Zhou, Mingxia, Dan Du, Chang Wang, et al.. (2023). EIF4A3-mediated circ_0042881 activates the RAS pathway via miR-217/SOS1 axis to facilitate breast cancer progression. Cell Death and Disease. 14(8). 559–559. 18 indexed citations
11.
Wang, Xuexin, et al.. (2023). Performance of 2D-shear wave elastography in autoimmune hepatitis-primary biliary cholangitis overlap syndrome. Abdominal Radiology. 48(4). 1290–1297. 1 indexed citations
12.
Du, Dan, Jing He, Chang Wang, et al.. (2023). When N7-methyladenosine modification meets cancer: Emerging frontiers and promising therapeutic opportunities. Cancer Letters. 562. 216165–216165. 21 indexed citations
13.
Jia, Jinlin, Suwen Wu, Jinxiu Sheng, et al.. (2022). Novel insights into m6A modification of coding and non-coding RNAs in tumor biology: From molecular mechanisms to therapeutic significance. International Journal of Biological Sciences. 18(11). 4432–4451. 16 indexed citations
14.
Wu, Bing, Song Zhang, Zengli Guo, et al.. (2021). The TGF-β superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation. Immunity. 54(2). 308–323.e6. 71 indexed citations
15.
Shi, Yingying, Mingxia Zhou, Junkai Yan, et al.. (2020). N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Mitigates Experimental Colitis Through Inhibition of Intestinal Mucosal Inflammatory Responses via MEK-ERK Signaling. Frontiers in Pharmacology. 11. 593–593. 10 indexed citations
16.
Xu, Weimin, Yuegui Guo, Zhenyu Huang, et al.. (2019). Small heat shock protein CRYAB inhibits intestinal mucosal inflammatory responses and protects barrier integrity through suppressing IKKβ activity. Mucosal Immunology. 12(6). 1291–1303. 37 indexed citations
17.
18.
Zhou, Mingxia, et al.. (2017). New Frontiers in Genetics, Gut Microbiota, and Immunity: A Rosetta Stone for the Pathogenesis of Inflammatory Bowel Disease. BioMed Research International. 2017. 1–17. 75 indexed citations
19.
He, Jing, Mingxia Zhou, Xinfeng Chen, et al.. (2016). Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma. Journal of Experimental & Clinical Cancer Research. 35(1). 98–98. 72 indexed citations
20.
Sheng, Lulu, et al.. (2015). miR-612 negatively regulates colorectal cancer growth and metastasis by targeting AKT2. Cell Death and Disease. 6(7). e1808–e1808. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026